IMITREX spray indications and usage: Difference between revisions

Jump to navigation Jump to search
(Created page with "__NOTOC__ {{Sumatriptan}} {{CMG}}; {{AE}} {{SS}} <ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = IMITREX (SUMATRIPTAN) SPRAY [GLAXOSMITHKLINE LL...")
 
mNo edit summary
 
Line 3: Line 3:
{{CMG}}; {{AE}} {{SS}}
{{CMG}}; {{AE}} {{SS}}


==Indications and Usage==


IMITREX® Nasal Spray is indicated for the acute treatment of migraine with or without aura in adults.


<ref name="dailymed.nlm.nih.gov">{{Cite web  | last = | first = | title = IMITREX (SUMATRIPTAN) SPRAY [GLAXOSMITHKLINE LLC] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=cc11b09d-e6cc-4cf8-1495-5ac64d5aae5f | publisher = | date = | accessdate = }}</ref>
====Limitations of Use====


* Use only if a clear diagnosis of migraine headache has been established. If a patient has no response to the first migraine attack treated with IMITREX, reconsider the diagnosis of migraine before IMITREX is administered to treat any subsequent attacks.


* IMITREX is not indicated for the prevention of migraine attacks.
* Safety and effectiveness of IMITREX Nasal Spray have not been established for cluster headache.<ref name="dailymed.nlm.nih.gov">{{Cite web  | last =  | first =  | title = IMITREX (SUMATRIPTAN) SPRAY [GLAXOSMITHKLINE LLC] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=cc11b09d-e6cc-4cf8-1495-5ac64d5aae5f | publisher =  | date =  | accessdate = }}</ref>


==References==
==References==

Latest revision as of 08:31, 1 February 2014

Sumatriptan
IMITREX injection® FDA Package Insert
Indications and Usage
Dosage and Administration
Dosage Forms and Strengths
Contraindications
Warnings and Precautions
Adverse Reactions
Drug Interactions
Use in Specific Populations
Overdosage
Description
Clinical Pharmacology
Nonclinical Toxicology
Clinical Studies
How Supplied/Storage and Handling
Patient Counseling Information
Labels and Packages
IMITREX tablet® FDA Package Insert
Indications and Usage
Dosage and Administration
Dosage Forms and Strengths
Contraindications
Warnings and Precautions
Adverse Reactions
Drug Interactions
Use in Specific Populations
Overdosage
Description
Clinical Pharmacology
Nonclinical Toxicology
Clinical Studies
How Supplied/Storage and Handling
Patient Counseling Information
Labels and Packages
IMITREX spray® FDA Package Insert
Indications and Usage
Dosage and Administration
Dosage Forms and Strengths
Contraindications
Warnings and Precautions
Adverse Reactions
Drug Interactions
Use in Specific Populations
Overdosage
Description
Clinical Pharmacology
Nonclinical Toxicology
Clinical Studies
How Supplied/Storage and Handling
Patient Counseling Information
Labels and Packages
Clinical Trials on Sumatriptan
ClinicalTrials.gov

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sheng Shi, M.D. [2]

Indications and Usage

IMITREX® Nasal Spray is indicated for the acute treatment of migraine with or without aura in adults.

Limitations of Use

  • Use only if a clear diagnosis of migraine headache has been established. If a patient has no response to the first migraine attack treated with IMITREX, reconsider the diagnosis of migraine before IMITREX is administered to treat any subsequent attacks.
  • IMITREX is not indicated for the prevention of migraine attacks.
  • Safety and effectiveness of IMITREX Nasal Spray have not been established for cluster headache.[1]

References

  1. "IMITREX (SUMATRIPTAN) SPRAY [GLAXOSMITHKLINE LLC]".

Adapted from the FDA Package Insert.